EFFICIENCY OF USING COMBINED ORAL CONTRACEPTIVES, ESTRADIOL VALERATE, AND GONADOTROPIN-RELEASING HORMONE ANTAGONIST FOR THE PROGRAMMING OF IN VITRO FERTILIZATION CYCLES
- 作者: MARTYNOVA M.Ѵ1, MISHIEVA N.G1, LEVKOV L.A1, MARTAZANOVA B.A1, LAPINA V.S1, BOGATYREVA K.A1, ABUBAKIROV A.N1
-
隶属关系:
- Research Center of Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
- 期: 编号 11 (2015)
- 页面: 46-52
- 栏目: Articles
- URL: https://journals.eco-vector.com/0300-9092/article/view/247529
- ID: 247529
如何引用文章
详细
全文:
作者简介
M. MARTYNOVA
Research Center of Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: Martinova_m@bk.ru
graduate student Moscow 117997, Ac. Oparina str. 4, Russia
N. MISHIEVA
Research Center of Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: nondoc555@mail.ru
MD, Senior researcher of l-st gynecology department. Moscow 117997, Ac. Oparina str. 4, Russia
L. LEVKOV
Research Center of Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: l_levkov@oparina4.ru
MD, PhD, Head of Department Moscow 117997, Ac. Oparina str. 4, Russia
B. MARTAZANOVA
Research Center of Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: bellamart88@mail.ru
graduate student Moscow 117997, Ac. Oparina str. 4, Russia
V. LAPINA
Research Center of Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: vslapina89@Gmail.ru
graduate student Moscow 117997, Ac. Oparina str. 4, Russia
Kh. BOGATYREVA
Research Center of Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: Eva-90-B@yandex.ru
graduate student Moscow 117997, Ac. Oparina str. 4, Russia
A. ABUBAKIROV
Research Center of Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: nondoc555@yahoo.com
PhD, Head of l-st gynecology department Moscow 117997, Ac. Oparina str. 4, Russia
参考
- Huirne J.A., Homburg R., Lambalk C.B. Are GnRH antagonists comparable to agonists for use in IVF? Hum. Reprod. 2007; 22(11): 2805-13.
- Garcia-Velasco J.A., Bermejo A., Ruiz F., Martinez-Salazar Requena A., Pellicer A. Cycle scheduling with oral contraceptive pills in the GnRH antagonist protocol vs the long protocol: a randomized, controlled trial. Fertil. Steril. 2011; 96(3): 590-3.
- GrowD., KawwassJ.F, KulkarniA.D., Durant T, Jamieson D.J., Macaluso M. GnRH agonist and GnRH antagonist protocols: comparison of outcomes among good-prognosis patients using national surveillance data. Reprod. Biomed. Online. 2014; 29(3): 299-304.
- Orvieto R., Batrizjo R GnRH agonist versus GnRH antagonist in ovarian stimulation: an ongoing debate. Reprod. Biomed. Online. 2013; 26(1): 4-8.
- Copperman A.B., Benadiva C. Optimal usage of the GnRH antagonists: a review of the literature. Reprod. Biol. Endocrinol. 2013; 11:20.
- Hauzman E.E., Zapata A., Bermejo A., Iglesias C., Pellicer A., Garcia- Velasco J.A. Cycle scheduling for in vitro fertilization with oral contraceptive pills versus oral estradiol valerate: a randomized, controlled trial. Reprod. Biol. Endocrinol. 2013; 11: 96.
- Sobotka V, Streda RMardesic I, TosnerJ., HeracekJ. Steroids pretreatment in assisted reproduction cycles. J. Steroid Biochem. Mol. Biol. 2014; 139: 114-21.
- Gelbaya T.A., Kyrgiou M., Tsoumpou I., Nardo L.G. The use of estradiol for luteal phase support in in vitro fertilization/intracytoplasmic sperm injection cycles: a systematic review and meta-analysis. Fertil. Steril. 2008; 90(6): 2116-25.
- Younis J.S., Soltsman S., Izhaki I., Radin 0., Bar-Ami S., Ben-Ami M. Early and short follicular gonadotropin-releasing hormone antagonist supplementation improves the meiotic status and competence of retrieved oocytes in in vitro fertilization-embryo transfer cycles. Fertil. Steril. 2010; 94(4): 1350-5.
- Blockeel C., Riva A., De Vos M., Haentjens P, Devroey P Administration of a gonadotropin-releasing hormone antagonist during the 3 days before the initiation of the in vitro fertilization/intracytoplasmic sperm injection treatment cycle: impact on ovarian stimulation. A pilot study. Fertil. Steril. 2011; 95(5): 1714-9.
- Frydman RForman R., Rainhorn J.D., Belaisch-Allart JHazout A., Testart J. A new approach to follicular stimulation for in vitro fertilization: programmed oocyte retrieval. Fertil. Steril. 1986; 46(4): 657-62.
- Wardle P.G., Foster PA., Mitchell J.D., McLaughlin E.A., Williams J.A., Corrigan E. et al. Norethisterone treatment to control timing of IVF cycle. Hum. Reprod. 1986; 1(7): 455-7.
- Zorn J.R., Boyer P, Guichard A. Never on a Sunday: programming for IVF- ET and GIFT. Lancet. 1987; 1(8529): 385-6.
- GerliS.,RemohiJ.,PartrizioP.,BorreroC.,BalmacedaJ.P,SilberSJ.,AschR.H. Programming of ovarian stimulation with norethindrone acetate in IVF/GIFT cycles. Hum. Reprod. 1989; 4(7): 746-8.
- Kolibianakis E.M., Papanikolaou E.G., Camus M., Toumaye H., Van Steirteghem A.C., Devroey P Effect of oral contraceptive pill pretreatment on ongoing pregnancy rates in patients stimulated with GnRH antagonists and recombinant FSH for IVF. A randomized controlled trial. Hum. Reprod. 2006; 21(2): 352-7.
- Griesinger G., Venetis C.A., Marx T, Diedrich K., Tarlatzis B.C., Kolibianakis E.M. Oral contraceptive pill pretreatment in ovarian stimulation with GnRH antagonists for IVF: a systematic review and metaanalysis. Fertil. Steril. 2008; 90(4): 1055-63.
- Andersen A.N., Witjes H, Gordon K., Mannaerts B.; Xpect investigators. Predictive factors of ovarian response and clinical outcome after IVF/ ICSI following a rFSH/GnRH antagonist protocol with or without oral contraceptive pre-treatment. Hum. Reprod. 2011; 26(12): 3413-23.
- Bermejo A., Iglesias C., Ruiz-Alonso M., Blesa D., Simon C., Pellicer A., Garcia-Velasco J. The impact of using the combined oral contraceptive pill for cycle scheduling on gene expression related to endometrial receptivity. Hum. Reprod. 2014; 29(6): 1271-8.
- Rombauts L., Healy D., Norman R.J.; Orgalutran Scheduling Study Group. A comparative randomized trial to assess the impact of oral contraceptive pretreatment on follicular growth and hormone profiles in GnRH antagonist-treated patients. Hum. Reprod. 2006; 21(1): 95-103.
- Griesinger G., Kolibianakis E.M., Venetis C., Diedrich K, Tarlatzis B. Oral contraceptive pretreatment significantly reduces ongoing pregnancy likelihood in gonadotropin-releasing hormone antagonist cycles: an updated meta-analysis. Fertil. Steril. 2010; 94(6): 2382-4.
- Fanchin R., Salomon L., Castelo-Branco A., Olivennes F, Frydman N., Frydman R. Luteal estradiol pre-treatment coordinates follicular growth during controlled ovarian hyperstimulation with GnRH antagonists. Hum. Reprod. 2003; 18(12): 2698-703.
- Cedrin-Durnerin I., Guivarc’h-Leveque A., Hugues J.N.; Groupe d’Etude en Medecine et Endocrinologie de la Reproduction. Pretreatment with estrogen does not affect IVF-ICSI cycle outcome compared with no pretreatment in GnRH antagonist protocol: a prospective randomized trial. Fertil. Steril. 2012; 97(6): 1359-64.
- Cedrin-Durnerin I., Bstandig B., Pameix I., Bied-Damon V, Avril C., Decanter C., Hugues J.N. Effects of oral contraceptive, synthetic progestogen or natural estrogen pre-treatments on the hormonal profile and the antral follicle cohort before GnRH antagonist protocol. Hum. Reprod. 2007; 22(1): 109-16.